<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-8705</journal-id>
<journal-title><![CDATA[CES Medicina]]></journal-title>
<abbrev-journal-title><![CDATA[CES Med.]]></abbrev-journal-title>
<issn>0120-8705</issn>
<publisher>
<publisher-name><![CDATA[Universidad CES]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-87052019000100003</article-id>
<article-id pub-id-type="doi">10.21615/cesmedicina.33.1.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de anticuerpos irregulares en donantes en un banco de sangre de Antioquia, 2016-2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of irregular antibodies in donors of the blood bank in Antioquia, 2016-2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flórez-Duque]]></surname>
<given-names><![CDATA[Jenniffer]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez-Álvarez]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Patiño Carreño]]></surname>
<given-names><![CDATA[Jaiver]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cardona-Arias]]></surname>
<given-names><![CDATA[Jaiberth Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad CES  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<volume>33</volume>
<numero>1</numero>
<fpage>3</fpage>
<lpage>12</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-87052019000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-87052019000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-87052019000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  la aloinmunización se presenta entre 1,0-1,5 % de las personas expuestas a un antígeno externo o durante el embarazo, un trasplante o una transfusión. En los bancos de sangre se realiza la tamización de anticuerpos irregulares, diferentes a los del sistema ABO.  Objetivo:  estimar la prevalencia de anticuerpos irregulares en donantes de un banco de sangre de Medellín entre 2016 y 2018.  Métodos:  estudio transversal en 25 391 donantes. Se realizó control de sesgos de selección e información mediante aplicación de técnicas con excelente validez y control de calidad interno y externo, y detección mediante ID-card Liss/coombs en seis microtubos con anti-IgG y anti-C3d. El análisis se basó en medidas de resumen, frecuencias, chi cuadrado y prueba exacta de Fisher.  Resultados:  la edad promedio fue 34 años. La prevalencia de anticuerpos irregulares fue 0,30 %, siendo mayor anti-D con 0,071 %. No se hallaron diferencias según el sexo y el grupo etario; anti-D fue más frecuente en mujeres y donantes entre 31 y 40 años.  Conclusión:  se halló una alta prevalencia de anti-D y antiKell, que presentan gran importancia clínica después de los anticuerpos del sistema ABO. Esto evidencia la necesidad de esta prueba para reducir las reacciones post-transfusionales.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Alloimmunization occurs between 1.0-1.5 % of people exposed to an external antigen or during pregnancy, a transplant or transfusion. In the blood banks, the screening of irregular antibodies different from those of the ABO system is performed.  Objective:  To estimate the prevalence of irregular antibodies in donors of a blood in Medellin 2016-2018.  Methods:  Cross-sectional study in 25 391 donors. Control of selection and information bias was carried out by applying techniques with excellent validity and internal and external quality control, and detection by ID-card Liss / coombs in six microtubes with anti-IgG and anti-C3d. The analysis was based on measures of summary, frequencies, chi-square and Fisher&#8217;s exact.  Results:  The average age was 34 years. The prevalence of irregular antibodies was 0.30%, being higher anti-D with 0.071%. No statistical differences were found according to sex and age group; Anti-D was more frequent in women and donors aged 31-40 years.  Conclusion:  A high prevalence of Anti-D and Anti-Kell was found, which are of great clinical importance after the antibodies of the ABO system. This demonstrates the need for this test to reduce post-transfusion reactions.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Prevalencia]]></kwd>
<kwd lng="es"><![CDATA[Anticuerpos irregulares]]></kwd>
<kwd lng="es"><![CDATA[Anticuerpos anti-D y anti-kell]]></kwd>
<kwd lng="es"><![CDATA[Donantes]]></kwd>
<kwd lng="es"><![CDATA[Bancos de sangre]]></kwd>
<kwd lng="en"><![CDATA[Prevalence]]></kwd>
<kwd lng="en"><![CDATA[Irregular antibodies]]></kwd>
<kwd lng="en"><![CDATA[Anti-D and anti-kell antibodies]]></kwd>
<kwd lng="en"><![CDATA[Donors]]></kwd>
<kwd lng="en"><![CDATA[blood banks]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aparecida-Mota]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality]]></article-title>
<source><![CDATA[Rev Bras Hematol Hemoter]]></source>
<year>2013</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>153-62</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daniels]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Poole]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Callaghna]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[MacLennan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The clinical significance of blood group antibodies]]></article-title>
<source><![CDATA[Transfusion Medicine]]></source>
<year>2002</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>287-95</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa-Ortega]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hoyos-González]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Rolón-Toledo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Villegas-García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de anticuerpos irregulares en donantes de un banco de sangre, 2012- 2015]]></article-title>
<source><![CDATA[Medicina transfusional al día]]></source>
<year>2016</year>
<volume>1</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>66</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñiz-Diaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Indicaciones actuales para la transfusión de hematíes de fenotipo compatible]]></article-title>
<source><![CDATA[Medicina transfusional al día]]></source>
<year>2014</year>
<volume>1</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>26-31</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñiz-Diaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pinacho-Oyarzabal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz-Murillo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfusión de sangre de fenotipo compatible. Indicaciones actuales]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Cortez-Vuelvas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Inmunología básica y aplicada]]></source>
<year>2014</year>
<page-range>195-209</page-range><publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Feriva]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="">
<collab>Ministerio Salud Pública</collab>
<source><![CDATA[Resolución 0901 de 1996]]></source>
<year>1996</year>
<page-range>1-40</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dueñas]]></surname>
<given-names><![CDATA[VH]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rovetto]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Neuta]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Embarazo y transfusión y su asociación con aloanticuerpos inesperados de significancia clínica contra antígenos eritrocitarios]]></article-title>
<source><![CDATA[Colombia Med]]></source>
<year>1999</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Makroo]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Raiput]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chowdhry]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Prakash, Karna]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India]]></article-title>
<source><![CDATA[Asian J Transfus Scl]]></source>
<year>2018</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villa]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detección de anticuerpos irregulares en pacientes transfundidos en una clínica de Medellín, Colombia entre 2007-2010]]></article-title>
<source><![CDATA[Hechos Microbiol]]></source>
<year>2012</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>17-24</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="">
<collab>Ministerio Salud</collab>
<collab>República de Colombia</collab>
<source><![CDATA[Resolución 8430 de 1993. Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="">
<collab>Ministerio Salud</collab>
<collab>República de Colombia</collab>
<source><![CDATA[Resolución 1995 de 1999. Por la cual se establecen normas para el manejo de la Historia Clínica]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="">
<collab>República de Colombia</collab>
<source><![CDATA[Constitución Política de 1991]]></source>
<year>1991</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bermúdez-Forero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dirección redes en salud pública. Coordinación red nacional de bancos de sangre y servicios de transfusión]]></article-title>
<source><![CDATA[Informe Anual Red de sangre]]></source>
<year>2017</year>
<page-range>47</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pahuja]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kushwaha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sethi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pujani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Screening of blood donors for erythrocyte alloantibodies]]></article-title>
<source><![CDATA[Heamtology]]></source>
<year>2012</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>302-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garg]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population]]></article-title>
<source><![CDATA[Transfus Apher Sci]]></source>
<year>2014</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>415-217</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero-Jiménez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anticuerpos monoclonales Anti-Rh: Antecedentes y estado actual]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2000</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>30-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñiz-Diaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cotorruelo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Nogués]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sistema Rh]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Cortez-Vuelvas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Inmunología básica y aplicada]]></source>
<year>2014</year>
<page-range>103-36</page-range><publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Feriva]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz-Espeletal]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Sáenz-Campos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Profilaxis de la sensibilidad Rh por transfusión de plaquetas en pacientes Rh negativos]]></article-title>
<source><![CDATA[Fármacos]]></source>
<year></year>
<volume>17</volume>
<numero>1/2</numero>
<issue>1/2</issue>
<page-range>17-23</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ameen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Eyaadi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Shemmari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chowshury]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Bashir]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuency of red blood cell alloantibody in Kuwaiti population]]></article-title>
<source><![CDATA[Med Princ Pract]]></source>
<year>2005</year>
<volume>14</volume>
<page-range>230-4</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anticuerpos irregulares, su importancia en medicina transfusional]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2005</year>
<volume>43</volume>
<numero>^ssupl 1</numero>
<issue>^ssupl 1</issue>
<supplement>supl 1</supplement>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tiwari]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shailja]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dixit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Raina]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of clinically significant antibodies in patients and healthy blood donors: A prospective cross-sectional study from a tertiary healthcare center in India]]></article-title>
<source><![CDATA[Transfusion and Apheresis Science]]></source>
<year>2014</year>
<volume>50</volume>
<page-range>230-4</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortes-Vuelvas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bautista]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[River]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez-Mora]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Payns-Romero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Importancia de la serotipificación completa en donantes]]></source>
<year>2012</year>
<conf-name><![CDATA[ 6ciclo internacional de conferencias de la calidad]]></conf-name>
<conf-loc>ciudad de México, México </conf-loc>
<page-range>1-37</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tormey]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Direct antiglobulin test: indications, interpretation, and pitfalls]]></article-title>
<source><![CDATA[Arch Pathol Lab Med]]></source>
<year>2017</year>
<volume>141</volume>
<page-range>305-10</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="">
<collab>Departamento Administrativo Nacional de Estadística DANE</collab>
<source><![CDATA[Nacimientos 2016]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molina-Giraldo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moise-Jr]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aloinmunización RH: manejo anteparto. Revisión de la literatura]]></article-title>
<source><![CDATA[Rev. Colomb. Obstet. Ginecol]]></source>
<year>2009</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>262-73</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vásquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pavez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mena]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia de antígenos del sistema sanguíneo Rh y del sistema Kell en donantes de sangre]]></article-title>
<source><![CDATA[Revista Cubana de Hematol, Inmunol y Hemoter]]></source>
<year>2015</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>160-71</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Magalhães]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mota]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pitombeira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-Transfus red cell alloimmunisation in patients with acute disorders and medical emergencies]]></article-title>
<source><![CDATA[Rev bras hematol hemoter]]></source>
<year>2007</year>
<volume>29</volume>
<page-range>369-72</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Isaza]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de anticuerpos irregulares eritrocitarios en pacientes con solicitud de concentrados de eritrocitos en dos clínicas de Bogotá, Colombia]]></source>
<year>2013</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
